Stem Cell-Based Cell Carrier for Targeted Oncolytic Virotherapy: Translational Opportunity and Open Questions

Oncolytic virotherapy for cancer is an innovative therapeutic option where the ability of a virus to promote cell lysis is harnessed and reprogrammed to selectively destroy cancer cells. Such treatment modalities exhibited antitumor activity in preclinical and clinical settings and appear to be well...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Janice, Hall, Robert R., Lesniak, Maciej S., Ahmed, Atique U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4690850/
https://www.ncbi.nlm.nih.gov/pubmed/26633462
http://dx.doi.org/10.3390/v7122921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4690850/
https://www.ncbi.nlm.nih.gov/pubmed/26633462
http://dx.doi.org/10.3390/v7122921

Ejemplares similares